 |
市場調査レポート
商品コード
1373843
フィルフィニッシュ製造の世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年）Global Fill Finish Manufacturing Market Size, Share, Growth Analysis, By Type(Consumables and Instruments), By Application(Oncology and Infectious Diseases, Autoimmune Diseases and Others.) - Industry Forecast 2023-20300 |
||||||
| フィルフィニッシュ製造の世界市場の規模、シェア、成長分析：タイプ別、用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月07日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のフィルフィニッシュ製造の市場規模は2021年に83億米ドルとなり、2022年の92億7,000万米ドルから2030年までに224億7,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで11.7%の成長が予測されています。
市場は近年安定した成長を示しています。これは、バイオ医薬品の需要増加、慢性疾患の流行、先進のドラッグデリバリーシステムの必要性といった要因によるものと考えられます。さらに、老年人口の拡大と個別化医療への関心の高まりが、フィルフィニッシュ製造サービスの需要を促進しています。バイアル、シリンジ、カートリッジ、アンプルなどの消耗品が市場で大きなシェアを占めています。プレフィルドシリンジの採用の増加や革新的な包装ソリューションへの需要が、フィルフィニッシュ製造における消耗品の成長を後押ししています。一方、充填機、キャッピング機、検査システムなど、フィルフィニッシュ製造に使用される機器は、効率向上とヒューマンエラー削減に向けた技術の進歩を見せています。これらの工程の自動化は、精度の向上、汚染リスクの低減、生産速度の向上につながっています。
世界のフィルフィニッシュ製造の市場力学
世界のフィルフィニッシュ製造市場の促進要因
バイオテクノロジー産業の成長
革新的な個別化された医薬品の開発に注力するバイオテクノロジー部門の拡大は、市場の主な促進要因です。この産業では、複雑で繊細なバイオ製品を効果的に包装および配送するために先進のフィルフィニッシュプロセスが求められており、市場に大きな成長機会をもたらしています。
世界のフィルフィニッシュ製造市場における抑制要因
製品の汚染に関する懸念
フィルフィニッシュ工程における製品の完全性の維持と汚染の防止は、医薬品製造においてもっとも重要です。製品の汚染や品質問題の発生は、製品のリコールやブランド評価の低下など、深刻な影響を及ぼす可能性があります。このため、厳格な品質管理対策を実施する必要があり、汚染のリスクに効果的に対処し軽減しなければならないフィルフィニッシュ製造市場に課題が提示されています。
世界のフィルフィニッシュ製造の主な市場動向
主な市場の動向の1つは、先進技術と自動化の採用の増加です。近年はフィルフィニッシュ工程における効率、精度、コンプライアンスを向上させるため、自動化システムや先進技術の利用への大きなシフトが見られます。
当レポートでは、世界のフィルフィニッシュ製造市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界のフィルフィニッシュ製造市場：タイプ別
- 市場の概要
- 消耗品
- 器具
世界のフィルフィニッシュ製造市場：用途別
- 市場の概要
- 腫瘍、感染症
- 自己免疫疾患、その他
世界のフィルフィニッシュ製造の市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Pfizer Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Novartis AG (Switzerland)
- Sanofi S.A. (France)
- Johnson & Johnson Services, Inc. (US)
- Eli Lilly and Company (US)
- AstraZeneca PLC (United Kingdom)
- Merck & Co., Inc. (US)
- GlaxoSmithKline plc (United Kingdom)
- Boehringer Ingelheim GmbH (Germany)
- Novo Nordisk A/S (Denmark)
- Bristol Myers Squibb Company (US)
- AbbVie Inc. (US)
- Amgen Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Biogen Inc. (US)
- Gilead Sciences, Inc. (US)
- Celgene Corporation (US)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
The Global Fill Finish Manufacturing Market size was valued at USD 8.3 billion in 2021 and is poised to grow from USD 9.27 billion in 2022 to USD 22.47 billion by 2030, growing at a CAGR of 11.7% in the forecast period (2023-2030).
The global fill finish manufacturing market has been experiencing steady growth in recent years. This can be attributed to factors such as the increasing demand for biopharmaceuticals, rising prevalence of chronic diseases, and the need for advanced drug delivery systems. Additionally, the expanding aging population and the growing focus on personalized medicine are driving the demand for fill finish manufacturing services. Consumables, such as vials, syringes, cartridges, and ampoules, account for a significant share of the market. The increasing adoption of prefilled syringes and the demand for innovative packaging solutions are propelling the growth of consumables in fill finish manufacturing. On the other hand, instruments used in fill finish manufacturing, such as filling machines, capping machines, and inspection systems, are witnessing technological advancements to improve efficiency and reduce human errors. The automation of these processes is gaining traction, leading to improved accuracy, reduced contamination risks, and increased production rates.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fill Finish Manufacturing Market Segmental Analysis
The Global Fill Finish Manufacturing Market is segmented by type, application, and region. Based on type, the market can be segmented into Consumables and Instruments. Based on application, the market is segmented into Oncology and Infectious Diseases, Autoimmune Diseases and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Fill Finish Manufacturing Market Dynamics
Drivers of the Global Fill Finish Manufacturing Market
Growing Biotechnology Industry
The expanding biotechnology sector, which focuses on the development of innovative and personalized medicines, is a key driver for the fill finish manufacturing market. This industry demands advanced fill finish processes to effectively package and deliver complex and sensitive biologic products, creating significant growth opportunities for the market.
Restraints in the Global Fill Finish Manufacturing Market
Concerns Regarding Product Contamination
Maintaining the integrity of products and preventing contamination during the fill finish process is of utmost importance in pharmaceutical manufacturing. Instances of product contamination or quality issues can have severe repercussions, including product recalls and damage to brand reputation. This necessitates the implementation of stringent quality control measures and poses challenges for the fill finish manufacturing market, which must address and mitigate the risk of contamination effectively.
Market Trends of Global Fill Finish Manufacturing Key
One key market trend in the global fill finish manufacturing market is the increasing adoption of advanced technologies and automation. Fill finish manufacturing refers to the final stages of the pharmaceutical production process, where the drug product is filled into vials, syringes, or other containers and then sealed and labeled. In recent years, there has been a significant shift towards the use of automated systems and advanced technologies to improve efficiency, precision, and compliance in the fill finish process.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Fill Finish Manufacturing Market by Type
- Market Overview
- Consumables and Instruments
- Global Fill Finish Manufacturing Market by Application
- Market Overview
- Oncology and Infectious Diseases
- Autoimmune Diseases and Others.
- Global Fill Finish Manufacturing Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celgene Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
